142.31 USD
+1.08
0.76%
At close Updated Sep 18, 3:17 PM EDT
1 day
0.76%
5 days
-2.2%
1 month
-7.55%
3 months
-12.57%
6 months
-15.37%
Year to date
-15.58%
1 year
24.49%
5 years
-36.27%
10 years
235.24%
 

About: Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Employees: 3,600

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

160% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $3.87M

7% more capital invested

Capital invested by funds: $9.03B [Q1] → $9.67B (+$638M) [Q2]

5.67% more ownership

Funds ownership: 100.38% [Q1] → 106.05% (+5.67%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 4 [Q1] → 4 (+0) [Q2]

7% less repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 136

5% less funds holding

Funds holding: 392 [Q1] → 373 (-19) [Q2]

26% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 58

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$198
39% upside
Avg. target
$204
43% upside
High target
$210
48% upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
BTIG
Marie Thibault
$198
Buy
Reiterated
11 Sep 2025
Piper Sandler
Jason Bednar
$210
Overweight
Maintained
6 Aug 2025

Financial journalist opinion

Based on 12 articles about MASI published over the past 30 days

Positive
Zacks Investment Research
yesterday
Here's Why Masimo (MASI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Masimo (MASI) is a Strong Growth Stock
Neutral
Business Wire
yesterday
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--A new study showed that universal surveillance monitoring with Masimo SET® pulse oximetry and Patient SafetyNet™ can yield significant cost savings.
New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs
Neutral
Business Wire
7 days ago
Masimo Announces Expansion of Strategic Partnership with Philips
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA). Building on over two decades of collaboration, this significant partnership expansion is designed to accelerate the integration of Masimo's monitoring technologies, such as industry-leading SET® pulse oximetry, into a variety of Philips multi-parameter patient monitors through 2026 and beyond. This includes integrating.
Masimo Announces Expansion of Strategic Partnership with Philips
Neutral
Seeking Alpha
13 days ago
Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Masimo Corporation (NASDAQ:MASI ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 1:30 PM EDT Company Participants Micah Young - Chief Financial Officer Catherine Szyman - CEO & Director Conference Call Participants Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Presentation Vikramjeet Chopra Associate Equity Analyst Okay. Good afternoon, everyone.
Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Positive
Zacks Investment Research
14 days ago
New Strong Buy Stocks for September 4th
LRN, RL, ATRO, MASI and BYD have been added to the Zacks Rank #1 (Strong Buy) List on September 4, 2025.
New Strong Buy Stocks for September 4th
Positive
Zacks Investment Research
21 days ago
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Post Holdings, Service Corporation International, TAL Education Group, Masimo and Okta.
Bet on 5 Top-Ranked Stocks With Rising P/E
Neutral
Business Wire
21 days ago
Masimo to Present in the Wells Fargo Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-le.
Masimo to Present in the Wells Fargo Healthcare Conference
Positive
Zacks Investment Research
24 days ago
Here is Why Growth Investors Should Buy Masimo (MASI) Now
Masimo (MASI) could produce exceptional returns because of its solid growth attributes.
Here is Why Growth Investors Should Buy Masimo (MASI) Now
Positive
Zacks Investment Research
24 days ago
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Masimo (MASI) is a Top Growth Stock for the Long-Term
Negative
Reuters
28 days ago
Masimo sues US Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading technology during a patent dispute between the companies.
Masimo sues US Customs over approval of Apple Watch imports
Charts implemented using Lightweight Charts™